RecruitingNot ApplicableNCT05607732

Primary Care Detection of Cognitive Impairment Leveraging Health & Consumer Technologies in Underserved Communities: The MyCog Trial

Sponsor

Northwestern University

Enrollment

45,257 participants

Start Date

Jan 30, 2024

Study Type

INTERVENTIONAL

Conditions

Cognitive Impairment Dementia Cognitive Decline Alzheimer Disease

Summary

Our study intends to offer 'real world' evidence of a viable, sustainable means to mobilize primary care via a comprehensive strategy for detecting cognitive impairment and dementias, advancing next steps for referral, and participating in the care planning and management of affected patients and caregivers. We will conduct a clinic-randomized, pragmatic trial testing the effectiveness and fidelity of our NIH Toolbox-derived paradigm to improve early detection and management of cognitive impairment/dementia in primary care settings serving health disparate patient populations.

Eligibility

Min Age: 45 Years

Plain Language Summary

Simplified for easier understanding

This trial is testing whether using consumer technology tools in primary care clinics can help doctors detect early memory problems and cognitive decline in older adults — especially in underserved communities. You may be eligible if: you are a patient who has seen an Oak Street Health provider at one of the enrolled clinics within the 3-year study period; you have had at least one clinic visit during that time; and you have not previously been diagnosed with memory loss, cognitive impairment, or dementia. You may NOT be eligible if: you are a child, teenager, or younger adult (this study focuses on older adults). Talk to your doctor to see if this trial is right for you.

This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.

Interested in this trial?

Get notified about updates and connect with the research team.

Interventions

DIAGNOSTIC_TESTMyCog

MyCog uses well-validated, self-administered, iPad-based measures from the NIH Toolbox for the Assessment of Neurological Behavior and Function Cognition Battery to provide an efficient and sensitive cognitive screen that can be easily implemented in primary care. Preliminary data shows these tests can discriminate between cognitively normal older adults and those with CI (specifically mild cognitive impairment); enabling physicians to assess CI in ways currently not available.